Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
MultiCell Technologies
MultiCell Technologies officials describe recent developments
February 14th, 2007
MultiCell Technologies officials describe recent developments. This trend article is an immediate alert from NewsRx to identify the most recent news developments at MultiCell Technologies. Report 1: MultiCell Technologies, Inc. (MCET), developing drugs based on immune system modulation and other proprietary technologies, announced it has obtained patent protection for its latest issued European patent in several countries, including France, Germany, Switzerland, U.K., Ireland, Belgium, Luxembourg and Monaco. This patent covers next generation technology from MCET, targeting multibillion-dollar medical marketplace segments,...
Source: Medical Patent Law Weekly (2007-02-14)
|
